Therapeutic Nuclease Platform

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a mission-driven company focused on advancing molecular research, diagnostics, and therapeutics through specialized enzymatic solutions derived from Arctic organisms. Its key achievement is the invention of salt-active nucleases and COD UNG, establishing it as a critical supplier to the global IVD and biomanufacturing industries. The company's strategy is to deepen its penetration in the high-growth gene therapy and vaccine manufacturing markets while expanding its therapeutic pipeline. With over 30 years of expertise, ArcticZymes combines a stable commercial enzyme business with a forward-looking therapeutic development arm.

Therapeutic Areas